Their study populations were patients with hyperthyroidism (including those with hyperactive nodules),4,8 or inpatients,15,19 and hepatic steatosis was defined using serum transaminase concentrations15 or both sonographic and serum ALT criteria.14 Contrastingly, our study only recruited newly diagnosed and untreated GD patients. This evidence concerns the gene GPT and fatty liver disease.